Skip to content

Compliance Matrix

An application with the strongest science in its review group can still be withdrawn from funding consideration over 10-point body text, a password-protected PDF or a line typed into the margin (NIH format rules). No reviewer is involved in any of it. NIH systems catch many of these faults at submission, and Center for Scientific Review staff screen every application for completeness and compliance before it reaches a study section (PA-27-100). Give the final check to someone who didn't write the science and will read each page the way an auditor would.

Download the one-page checklist (PDF)

Formatting Rules for Every PDF

  • Font size - 11 points or larger for body text. Text inside figures can run smaller as long as it stays legible at 100% zoom.
  • Type density - no more than 15 characters per linear inch and six lines per vertical inch.
  • Fonts - Arial, Georgia, Helvetica and Palatino Linotype all meet the standard, and any other font that passes the size and density rules is accepted.
  • Page and margins - letter-size pages with margins of at least half an inch on every side. Keep everything you supply out of the margins.
  • Headers and footers - leave both off your files, because NIH adds its own when it assembles the application.
  • Security - switch off every PDF security feature. NIH systems have to open each file, so passwords and encryption aren't allowed.
  • Flattening - flatten any PDF that has fillable fields, layers or inserted elements, since an unflattened file can trigger an eRA Commons error.
  • Signatures - an electronic signature can't stay live in an attachment. Sign the document, then flatten it.
  • Scans - create text documents in a word processor and convert them to PDF. Scan only signed pages, such as letters of support.
  • File names - keep each to 50 characters or fewer, unique within the application and free of ampersands.
  • Links - URLs are allowed only where the announcement or form instructions permit them, and the URL itself has to be the visible link text.

Page Limits at a Glance

Section Phase I (R43) Phase II, Fast-Track, Direct to Phase II (R44)
Project Summary/Abstract 30 lines 30 lines
Project Narrative 3 sentences 3 sentences
Specific Aims 1 page 1 page
Research Strategy 6 pages 12 pages
Commercialization Plan Not allowed 12 pages
Introduction to a resubmission 1 page 1 page
Regulatory Plan, clinical trials only 2 pages 2 pages

Limits are from NIH's Table of Page Limits, and the Regulatory Plan limit is from PA-27-100.

Form Entries That Block Submission

Each principal investigator's eRA Commons ID goes in the Credential field of the Senior/Key Person Profile, and without a valid ID the application can't be submitted electronically. The Unique Entity Identifier on the application has to match the one held in SAM.gov and in your eRA Commons organization profile. If you answer "Yes" to human subjects on the R&R Other Project Information form, you'll need at least one study record or a Delayed Onset Study record.

Trial applications attach the Regulatory Plan as "RegulatoryPlan.pdf" under Other Attachments on that same form. Any company that already holds an SBIR Phase II award from a federal agency must add its Phase II commercialization history (NIH Form G.440). PA-27-100 drops the Data Management and Sharing Plan, though Resource Sharing Plans still follow the Application Guide.

Overlap and Duplication Rules

NIH won't accept essentially identical applications filed at the same time under PA-27-100 and another HHS announcement, and the STTR parent counts as one of those. Resubmissions run on their own clock. An A1 can't go in until NIH has issued the summary statement for the A0, and a new application can't go in while an overlapping one is still waiting for its summary statement. NIH also refuses derivative applications that propose the same product with non-substantive changes for different uses.

Paying for work abroad has its own rule. Any subaward or subcontract to a foreign entity makes the application noncompliant. Unfunded foreign collaborators, foreign consultants and equipment bought from foreign vendors are still allowed.

NIH makes the applicant responsible for viewing the assembled application in eRA Commons before the due date. Set aside time on the last day for one full read of that version.